Alzheon ALZ-801 Data Presented in Oral Session at CTAD on Role of Amyloid Oligomers in Alzheimer’s Disease - Press Release
Digital Journal,
FRAMINGHAM, Mass.--(Business Wire)-- Alzheon, Inc., a clinical-stage biopharmaceutical company focused on developing new…